Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2021-05-24
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future: Intelligent ICU of the Future
NCT03905668
Exploring the Use of AI-Assisted Video Monitoring to Predict Accidental Events in ICU Patients
NCT07307521
Neurosteer Bedside Monitoring System
NCT06718764
Utilizing Technology for Optimization of Pain Management and Mobilization in High Risk Cardiac Surgical ICU Patients
NCT04146727
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
NCT06935513
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to evaluate the ability of the investigators' proposed model to leverage accelerometer, environmental, circadian rhythm biomarkers, and video data in autonomously quantifying pain, characterizing functional activities, and delirium status. The Autonomous Delirium Monitoring and Adaptive Prevention (ADAPT) system will use novel pervasive sensing and deep learning techniques to autonomously quantify patients' mobility and circadian dyssynchrony in terms of nightly disruptions, light intensity, and sound pressure level. This will allow for the integration of these risk factors into a dynamic model for predicting delirium trajectories. Commercially available cameras will be used to monitor patients' facial expressions and contextualize patients' actions by providing imaging data to provide additional patient movement information. Commercially available environmental sensors will be used to provide data on illumination, decibel level, and air quality. Patient blood samples will help determine their circadian rhythm and compare and validate the pervasive sensing system's capabilities of autonomously monitoring circadian dyssynchrony. Electronic health record data will also be collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adult ICU patients
adult patients aged 18 or older admitted to University of Florida Health Shands Gainesville ICU wards
Video Monitoring
continuous video monitoring
Accelerometer Monitoring
continuous accelerometer monitoring of patient movements
Noise Level Monitoring
continuous environmental noise monitoring
Light Level Monitoring
continuous environmental light monitoring
Air Quality Monitoring
continuous environmental air quality monitoring
EKG Monitoring
continuous EKG monitoring
Vitals Monitoring
continuous vitals monitoring (heart rate, oxygen saturation)
Biosample Collection
blood and urine samples collected once on Day 1 and once on Day 2
Delirium Motor Subtyping Scale 4 (DMSS-4)
done daily on delirious patients to subtype delirium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video Monitoring
continuous video monitoring
Accelerometer Monitoring
continuous accelerometer monitoring of patient movements
Noise Level Monitoring
continuous environmental noise monitoring
Light Level Monitoring
continuous environmental light monitoring
Air Quality Monitoring
continuous environmental air quality monitoring
EKG Monitoring
continuous EKG monitoring
Vitals Monitoring
continuous vitals monitoring (heart rate, oxygen saturation)
Biosample Collection
blood and urine samples collected once on Day 1 and once on Day 2
Delirium Motor Subtyping Scale 4 (DMSS-4)
done daily on delirious patients to subtype delirium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to UF Health Shands Gainesville ICU ward
* expected to remain in ICU ward for at least 24 hours at time of screening
Exclusion Criteria
* on any contact/isolation precautions
* expected to transfer or discharge from the ICU in 24 hours or less
* unable to provide self-consent or has no available proxy/LAR
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
NIH
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Azra Bihorac, MD, MS
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida Health Shands Hospital
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Davoudi A, Malhotra KR, Shickel B, Siegel S, Williams S, Ruppert M, Bihorac E, Ozrazgat-Baslanti T, Tighe PJ, Bihorac A, Rashidi P. Intelligent ICU for Autonomous Patient Monitoring Using Pervasive Sensing and Deep Learning. Sci Rep. 2019 May 29;9(1):8020. doi: 10.1038/s41598-019-44004-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.